Document Detail

Pediatric Drug-Trial Recruitment: Enticement Without Coercion.
MedLine Citation:
PMID:  21464193     Owner:  NLM     Status:  Publisher    
Despite federal initiatives to increase research and expand data about the effectiveness and safety of medications in children, data are still limited for this population. One of the most salient barriers to conducting pediatric clinical trials involves participant recruitment. In this article, we summarize recruitment challenges including a lack of research infrastructure, the need to properly define appropriate use of incentives and payments, and inconsistencies in the current use of payments and incentives. We also searched the and databases for updated data on current practices in pediatric participant compensation/payment. We provide recommendations for tackling current barriers to recruiting and retaining children and families in clinical trials.
Carl L Tishler; Natalie Staats Reiss
Related Documents :
17056493 - The marc dax (1770-1837)/paul broca (1824-1880) controversy over priority in science: l...
21482573 - Emerging perspectives in social neuroscience and neuroeconomics of aging.
16208843 - Community without communitarianism: hiv/aids research, prevention and treatment in aust...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-4
Journal Detail:
Title:  Pediatrics     Volume:  -     ISSN:  1098-4275     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376422     Medline TA:  Pediatrics     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Psychology, Ohio State University, Columbus, Ohio; and.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cost-effectiveness of Metered-Dose Inhalers for Asthma Exacerbations in the Pediatric Emergency Depa...
Next Document:  Fatal Coronary Artery Disease in an Infant With Severe Mucopolysaccharidosis Type I.